Devyser Diagnostics AB (publ) (STO: DVYSR)
Sweden
· Delayed Price · Currency is SEK 133.00
+1.00 (0.76%)
Nov 20, 2024, 5:29 PM CET
Devyser Diagnostics AB Market Cap
Devyser Diagnostics AB has a market cap or net worth of 2.20 billion as of November 21, 2024. Its market cap has increased by 132.48% in one year.
Market Cap
2.20B
Enterprise Value
2.09B
Revenue
198.10M
Ranking
n/a
PE Ratio
n/a
Stock Price
133.00
Market Cap Chart
Since December 10, 2021, Devyser Diagnostics AB's market cap has increased from 1.35B to 2.20B, an increase of 62.44%. That is a compound annual growth rate of 17.89%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Nov 20, 2024 | 2.20B | 71.55% |
| Dec 29, 2023 | 1.28B | 11.06% |
| Dec 30, 2022 | 1.15B | -14.36% |
| Dec 30, 2021 | 1.35B | -0.45% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| AstraZeneca PLC | 2,154.31B |
| Swedish Orphan Biovitrum AB (publ) | 103.72B |
| Sectra AB (publ) | 52.88B |
| Getinge AB (publ) | 46.60B |
| Camurus AB (publ) | 32.02B |
| Vitrolife AB (publ) | 29.65B |
| Medicover AB (publ) | 26.06B |
| Elekta AB (publ) | 24.07B |